What items must be included in the labeling of non-sterile compounded products?

The correct answer includes the name of each active ingredient, an internal control number, and the beyond-use date because these elements are essential for ensuring patient safety and the proper dispensing of non-sterile compounded products.

Including the name of each active ingredient is crucial for transparency and allows healthcare providers and patients to understand exactly what substances are in the compounded product. This is particularly important for patients who may have allergies or sensitivities to certain ingredients, as well as for healthcare professionals tasked with monitoring interactions with other medications.

The internal control number serves as a tracking mechanism for the compounded product. It allows pharmacies to maintain quality control and traceability in case of a recall or adverse event related to that specific batch. This feature is vital for maintaining regulatory compliance and promoting patient safety.

Finally, the beyond-use date is essential because it indicates how long the compounded product can be expected to retain its potency and safety. This date must be clearly labeled to advise users regarding the time frame within which the product should be used.

Incorporating these elements into the labeling helps to ensure that the compounded products are safe, effective, and comply with regulations established by the pharmacy practice standards. The other choices lack some of these critical labeling components and therefore do not fulfill the requirements for non